Market Insights: Varonis Systems Inc (VRNS)’s Notable Drop of -0.76, Closing at 43.18

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

As of close of business last night, Varonis Systems Inc’s stock clocked out at $43.18, down -0.76% from its previous closing price of $43.51. In other words, the price has decreased by -$0.76 from its previous closing price. On the day, 0.76 million shares were traded. VRNS stock price reached its highest trading level at $43.85 during the session, while it also had its lowest trading level at $43.0.

Ratios:

To gain a deeper understanding of VRNS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 86.73. For the most recent quarter (mrq), Quick Ratio is recorded 2.43 and its Current Ratio is at 2.43. In the meantime, Its Debt-to-Equity ratio is 0.64 whereas as Long-Term Debt/Eq ratio is at 0.62.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wedbush on February 06, 2024, Upgraded its rating to Outperform and sets its target price to $65 from $35 previously.

On January 18, 2024, DA Davidson Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $37 to $45.

On December 15, 2023, Susquehanna started tracking the stock assigning a Positive rating and target price of $55.Susquehanna initiated its Positive rating on December 15, 2023, with a $55 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 29 ’24 when Iohan Gili sold 19,500 shares for $50.54 per share. The transaction valued at 985,530 led to the insider holds 19,263 shares of the business.

Kess Avrohom J. bought 230 shares of VRNS for $11,902 on Feb 12 ’24. The Director now owns 23,262 shares after completing the transaction at $51.75 per share. On Feb 09 ’24, another insider, Bass David, who serves as the EVP Engineering and CTO of the company, sold 13,675 shares for $51.58 each. As a result, the insider received 705,338 and left with 637,997 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRNS now has a Market Capitalization of 4711110656 and an Enterprise Value of 4488186880. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.44 while its Price-to-Book (P/B) ratio in mrq is 9.62. Its current Enterprise Value per Revenue stands at 8.991 whereas that against EBITDA is -42.534.

Stock Price History:

Over the past 52 weeks, VRNS has reached a high of $52.88, while it has fallen to a 52-week low of $22.34. The 50-Day Moving Average of the stock is -10.69%, while the 200-Day Moving Average is calculated to be 11.73%.

Shares Statistics:

It appears that VRNS traded 1.26M shares on average per day over the past three months and 956390 shares per day over the past ten days. A total of 109.10M shares are outstanding, with a floating share count of 104.50M. Insiders hold about 4.22% of the company’s shares, while institutions hold 97.13% stake in the company. Shares short for VRNS as of 1711584000 were 6882736 with a Short Ratio of 5.46, compared to 1709164800 on 6297992. Therefore, it implies a Short% of Shares Outstanding of 6882736 and a Short% of Float of 7.21.

Earnings Estimates

The current assessment of Varonis Systems Inc (VRNS) involves the perspectives of VeriSign, Inc. analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $1.41, with high estimates of $16.10 and low estimates of $43.18.

Analysts are recommending an EPS of between $Healthcare and $Technology for the fiscal current year, implying an average EPS of $Healthcare.

Most Popular

[the_ad id="945"]